Format

Send to

Choose Destination
Transplant Proc. 2015 Oct;47(8):2377-9. doi: 10.1016/j.transproceed.2015.08.029.

Present and Future of Regenerative Medicine: Liver Transplantation.

Author information

1
Servei Cirurgia Hepatobiliopancreàtica i Trasplants, Hospital Universitari Vall Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: mcaralt@vhebron.net.

Abstract

In recent years, the creation of new organs using bioengineering has been proposed as a possible solution to the shortage of organs for transplantation. After decellularization of livers, the remaining extracellular matrix can be used as scaffolds that can be reseeded with different kinds of cells. Mature hepatocytes and fetal liver cells have been used, showing viability, functionality, and differentiation into mature cells. After perfusion in a bioreactor, the seeded scaffold or liver organoid may be transplanted. However, viability of these transplanted scaffolds is poor owing to the formation of thrombosis. We analyzed the recent advances in decellularizing and recellularizing and the results after transplantation reported in the literature.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center